Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FMK3B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,435
Award facts
- Contract value 100% obligated
- $10,434.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,434.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.5 mL syringes of Vaxneuvance, a pneumococcal vaccine. The order, issued on January 14, 2026, with a completion date of January 15, 2026, represents a non-set-aside competitive award with place of performance in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive medical product procurement for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The larger SPE2DX contract vehicle enables AmerisourceBergen to supply essential medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA Troop Support planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FMK3B?
SPE2DR26FMK3B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FMK3B worth?
The government has obligated $10,435 on SPE2DR26FMK3B.
Is contract SPE2DR26FMK3B an order under another contract?
Yes. SPE2DR26FMK3B is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK3B competed?
The extent of competition for SPE2DR26FMK3B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award